Skip to main content

Advertisement

SpringerLink
Log in

Human papillomavirus vaccine: Urgent need to promote gender parity

  • COMMENTARY
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Shield KD, Marant Micallef C, de Martel C, Heard I, Megraud F, Plummer M, et al. New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis. Eur J Epidemiol. 2018. https://doi.org/10.1007/s10654-017-0334-z.

    Google Scholar 

  2. Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Prim. 2016;2:16086.

    Article  PubMed  Google Scholar 

  3. de Sanjosé S, Brotons M, Pavón MA. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol. 2017;47:2–13.

    Article  PubMed  Google Scholar 

  4. HCSP. Vaccination des garçons contre les infections à papillomavirus. 2016. http://www.hcsp.fr/Explore.cgi/Telecharger?NomFichier=hcspr20160219_recovaccinfhpvhommes.pdf.

  5. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4:e609–16.

    Article  PubMed  Google Scholar 

  6. de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141:664–70.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Pincock S. Virologist wins Nobel for cervical cancer discovery. Lancet. 2008;372:1374.

    Article  PubMed  Google Scholar 

  8. Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, et al. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer. 2015;136:2752–60.

    Article  CAS  PubMed  Google Scholar 

  9. Brotherton JML, Bloem PN. Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage. Best Pract Res Clin Obstet Gynaecol. 2017;47:42–58.

    Article  PubMed  Google Scholar 

  10. Michels KB, zur Hausen H. HPV vaccine for all. Lancet. 2009;374:268–70.

    Article  PubMed  Google Scholar 

  11. Uhart M, Adam M, Dahlab A, Bresse X. Loss of chance associated with sub-optimal HPV vaccination coverage rate in France. Papillomavirus Res. 2017;3:73–9.

    Article  PubMed  Google Scholar 

  12. Fonteneau L, Ragot M, Parent du Châtelet I, Guthmann J-P, Lévy-Bruhl D. The use of reimbursement data for timely monitoring of vaccination coverage: the example of human papillomavirus vaccine following public concerns about vaccine safety. BMC Public Health. 2015;15:1233.

    Article  PubMed  PubMed Central  Google Scholar 

  13. HCSP. Avis relatif à la révision de l’âge de vaccination contre les infections à papillomavirus humains des jeunes filles. 2012. http://www.hcsp.fr/Explore.cgi/Telecharger?NomFichier=hcspa20120928_agevaccpapilljeunesfilles.pdf.

  14. HCSP. Vaccinations des personnes immunodéprimées ou aspléniques_Recommandations. 2012. http://www.hcsp.fr/Explore.cgi/Telecharger?NomFichier=hcspr20120712_vaccinationimmunodeprime.pdf.

  15. Ventimiglia E, Horenblas S, Muneer A, Salonia A. Human papillomavirus infection and vaccination in males. Eur Urol Focus. 2016;2:355–62.

    Article  PubMed  Google Scholar 

  16. INCa. Plan cancer 2014–2019. 2015. http://www.e-cancer.fr/content/download/123552/1485522/file/Plan_cancer_2014-2019-PNRT.pdf.

  17. Fonteneau L, Guthmann J-P, Lévy-Bruhl D. Estimation des couvertures vaccinales en France à partir de l’Échantillon généraliste des bénéficiaires (EGB): exemples de la rougeole, de l’hépatite B et de la vaccination HPV. Bull Epidemiol Hebd. 2013;7:72–6.

    Google Scholar 

  18. Brotherton JM, Winch KL, Bicknell L, Chappell G, Saville M. HPV vaccine coverage is increasing in Australia. Med J Aust. 2017;206:262.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. IRD, MEPHI, AP-HM, IHU-Méditerranée-Infection, Aix-Marseille University, Marseille, France

    Cédric Abat & Didier Raoult

Authors
  1. Cédric Abat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Didier Raoult
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Didier Raoult.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abat, C., Raoult, D. Human papillomavirus vaccine: Urgent need to promote gender parity. Eur J Epidemiol 33, 259–261 (2018). https://doi.org/10.1007/s10654-018-0365-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-018-0365-0

Keywords

Search

Navigation